Vijay Agarwal, MD
Founder, President and CEO
Company Overview
Alpheus Medical is a private, clinical-stage biotechnology company developing a novel therapeutic approach based on Porphyrin Metabolite Activation (PoMA). This drug-centered strategy leverages a molecule that preferentially accumulates in tumor cells, followed by activation using low-intensity ultrasound to enable localized pharmacologic effect. This non-invasive approach is designed to activate the molecule directly within tumor cells while minimizing systemic therapy exposure, potentially addressing the diffuse nature of the disease.
Built on a growing foundation of evidence, the company’s lead program focuses on glioblastoma and is currently under clinical investigation.
Leadership
Management Team
Board of Directors
Klaus Veitinger, MD, Ph.D
Executive Chairman of the Board
John Johnson
HealthQuest Capital
Juan-Pablo Mas
Synapse Fund
Robert Stein, MD, Ph.D
Samsara BioCapital
Peter Thomson, MD
OrbiMed Advisors
Scientific Advisory Board
Investors
Vijay Agarwal, MD
/in Leadership, Board of Directors/by David AndersonFounder, President and CEO
Imran Eba
/in Leadership/by David AndersonChief Financial Officer
Jeremy Ling
/in Leadership/by David AndersonChief Technology Officer
Ann-Marie Hulstine
/in Leadership/by David AndersonVice President, Clinical Operations
Mike Preigh, Ph.D
/in Leadership/by David AndersonVice President, Chemistry, Manufacturing & Controls (CMC)
Nick Ellens, Ph.D
/in Leadership/by David AndersonVice President, Research & Development